Strength measurements of the shoulder internal and external rotators of boxers. by Yavuz Yasul (18605628)

Subjects:

An overview of diet and exercise for boxers demonstrates. by Yavuz Yasul (18605628)

Subjects:

Physiological parameters related to body mass, BMI and body fat percentage in boxers. by Yavuz Yasul (18605628)

Subjects:

Strength measurements in the knee extensors and flexors of boxers. by Yavuz Yasul (18605628)

Subjects:

Variations in the force coefficients. by Shantanu S. Bhat (5446082)

Subjects:

Inertial loads. by Shantanu S. Bhat (5446082)

Subjects:

Decreased thrombin activity levels in PAR KO following 24 hours following ischemia. by Efrat Shavit-Stein (3186678)

“…<p>(A) Total thrombin activity is significantly decreased in PAR1 KO compared to WT mice (t-test). …”

Fluctuation trend of the mean temperature index. by Chengyuan Hao (21615653)

“…Secondly, the daily minimum and maximum temperatures increased significantly, which were 0.395°C/10a and 0.200°C/10a respectively<b>—</b>less than the national mean. …”

Variation curve of the mean temperature index. by Chengyuan Hao (21615653)

“…Secondly, the daily minimum and maximum temperatures increased significantly, which were 0.395°C/10a and 0.200°C/10a respectively<b>—</b>less than the national mean. …”

<b>Glucagon Clearance is Decreased in Chronic Kidney Disease, but Preserved in Liver Cirrhosis</b> by Magnus F. G. Grøndahl (19160825)

Feature importance scores based on log-variance features for a representative participant. by Sinan Uslu (17636400)

Subjects:

Estimated mean values for light interception. by Torsten Schober (20485754)

“…In contrast to expectations, neither PD nor DVP had significant effects on the cannabinoid concentration gradient from upper to lower canopy layers. …”

Joint moment data from the lower limb joints. by Eric Yung-Sheng Su (13015474)

Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during letrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects:

Flowchart of patient selection in this study. by Kazuyoshi Ohkawa (836847)

Subjects:

Changes in the FIB-4 index in breast cancer patients with a FIB-4 index of ≥ 2.67 during letrozole and anastrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects:

Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during anastrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects:

Clinical features and cancer treatment in patients with breast cancer receiving letrozole and anastrozole. by Kazuyoshi Ohkawa (836847)

Subjects:

S1 Data - by Kazuyoshi Ohkawa (836847)

Subjects:

Clinical course of patient no. by Kazuyoshi Ohkawa (836847)

Subjects: